Huntington's disease (HD) and Dentatorubral and pallidoluysian atrophy (DRPLA) are autosomal dominant, neurodegenerative disorders caused by the expansion of polyglutamine tracts in their respective proteins, huntingtin and atrophin-1. We have previously generated mouse models of these disorders, using transgenes expressed via the prion protein promoter. Here, we report the first direct comparison of abnormalities in these models. The HD mice show abbreviated lifespans (4 -6 months), hypoactivity, and mild impairment of motor skills. The DRPLA mice show severe tremors, are hyperactive, and are profoundly uncoordinated. Neuropathological analyses reveal that the distribution of diffuse nuclear immunolabeling and neuronal intranuclear inclusions (NII's), in the CNS of both models, was remarkably similar. Cytoplasmic aggregates of huntingtin were the major distinguishing neuropathological feature of the HD mice; mutant atrophin-1 accumulated/aggregated only in the nucleus. We suggest that the distinct behavioral and neuropathological phenotypes in these mice reflect differences in the way these mutant proteins perturb neuronal function.
INTRODUCTION
HD and DRPLA are autosomal dominant, progressive disorders caused by expansions of polyglutamine tracts in their respective proteins, huntingtin (Huntington' s Disease Collaborative Group, 1993) and atrophin-1 (Koide et al., 1994; Nagafuchi et al., 1994) . HD is caused by expansions of more than 36 CAG's in huntingtin (Rubinsztein et al., 1996) , whereas DRPLA is associated with expansions of more than 49 CAG's in atrophin-1 (Koide et al., 1994) . Both diseases share several features but the patterns of cell death differ (Albin et al., 1995; Ross et al., 1997a,b) . In HD postmortem brain, caudate and putamen are the most affected areas, whereas in DRPLA postmortem brain, cerebellar dentate nucleus, subthalamic nucleus, and globus pallidus display the most severe degeneration of neurons (Ross et al., 1997a) . Postmortem brains from patients with either disease show neuronal intranuclear inclusions composed of apparently aggregated polyglutamine proteins (DiFiglia et al., 1997; Becher et al., 1998; Hayashi et al., 1998; Igarashi et al., 1998) .
Neuronal intranuclear inclusions (NII's) were first described in transgenic mice expressing the first exon of huntingtin with 115-156 CAG's (Mangiarini et al., 1996; Davies et al., 1997) . Subsequently, NII's were
